Awesome Spcl reverse merger into 48 million a year pixel

New Post Public Reply Private Reply Replies (1) Message Board
Pugilista
Awesome Spcl reverse merger into 48 million a year pixel mags




DD on SPCL – Super Value here.. Courtesy of HokieHead

With the pending reverse merger and splits involved I decided to analyze the change in share structure, give details on the share structure and most importantly come up with a valuation of the current shares.

My valuation on the current shares places the shares at a target of $0.0022 (worse case) to $0.0263 (best case), that’s a 633% to 8,667% gain. Below I will show how I came to these figures. Say I’m crazy but this reverse merger (look at the merger, not the split!) is a mother lode.

Let’s look at the share structures first:

Current:
Authorized: 2.17 Billion
Commons: 2.16 Billion
Preferred: 10 Million

Outstanding: 1.83 Billion
Current PPS: $0.0003
Current Market Cap: $549,000

After Merger/Splits:
Authorized (1/10): 217 Million
Commons (less preferred): 207 Million
Preferred (no change): 10 Million

Outstanding (1/100): 18.3 Million
Post-Merger/Split PPS (1/100): $0.03
Post-Merger/Split Market Cap: $549,000

Until we see the financials on the new company, from the DD I’ve done, PixelMags revenues are in the $48 million range and growing. These 3 sites confirm it:

http://listings.findthecompany.com/l/18058157...Angeles-CA

http://www.zoominfo.com/c/PixelMags-Inc/353841771

http://www.buzzfile.com/business/Pixelmags,-Inc-310-598-7303

I kept the valuation of the incoming company to a 1x sales valuation for simplicity. Price to Sales ratios in the Software & Programming industry average anywhere from 4-9x sales so I’m low balling this as well.

http://csimarket.com/Industry/industry_valuat...p;ind=1011

Best Case:
Putting a $48 million market cap (1x sales) on the post-merger company with the post-split outstanding of 18.3 million shares, that would place the PPS at $2.63 ($48m/18.3m os), or $0.0263 pre-merger/split, that’s 87x higher than the current PPS.

Worse Case:
Putting a $48 million market cap (1x sales) on the post-merger company with the post-split shares maxed out at the 217 million authorized shares (maxed out but I don’t see this happening), that would place the PPS at $0.22 ($48m/217m as), or $0.0022 pre-merger/split, or 7x higher than the current PPS.

Conclusion:
Let’s wait the see the filings, etc. but currently SPCL is 7-88x undervalued at this level imo. Those that are only looking at the reverse split and saying this is a bad thing are caught in the penny scam mindset that all reverse splits are bad. Look at the incoming value of the merger! The current SPCL shareholders will own just over 8% of the incoming company. This will be a company with $50 million in revenues and growing, 217 million shares authorized, 18 million shares outstanding and only a $550,000 market cap. Even if you maxed out the shares to the authorized post-split (won’t happen) you have only a $6.5 million market cap. That’s trading at .13x sales, cheap!

This imo is like getting in on a big technology IPO at inside ownership levels. Do some DD on PixelMags; this would be a hot hot play if they were coming public through the more expensive IPO route. The reverse merger route is cheaper and better for everyone involved. I would rather own 8% of PixelMags, a possible hot tech play (FB, GOOG, etc.) that will most likely up list to a major exchange and garner a market cap in the $100’s of millions than 100% of SPCL, or basically nothing.

Anyone remember TTC*, announced a merger with a software company and with close to 3 billion in outstanding shares ran from $0.0004 to $0.037 in a few months. $1,000 invested there at $0.0004 went to $92,500 at $0.037.

http://stockcharts.com/h-sc/ui?s=TTCM&p=D...8775116615

That company did not already have close to $50 million in revenues like PixelMags has, had a bigger share structure and still ran almost a 100 times higher. SPCL will be bigger. If you own and have shares at this level congrats, I think big things coming here in the next few weeks and months. Don’t let anyone try and talk you out of your shares.

Solaris Power Cells, Inc (SPCL) Stock Research Links

SPCL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 4

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 3

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 3

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Updated Category News Views 3

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 3

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 2

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading

Top 5 Most Recently Viewed Articles

Breakthrough Gene Therapy Study Offers Hope for Danon Disease

Updated Category News Views 110

Revolutionary Advances in Gene Therapy for Danon Disease Recent findings from groundbreaking research at Children's Hospital of Philadelphia reveal a promising new approach in tackling Danon disease, a complex genetic disorder predominantly affecting young males. The study not only highlights the potential of gene therapy—specifically a novel treatment known as...

Continue Reading
Biohaven Doses First Patient with Innovative BHV-8100

Updated Category News Views 4

Biohaven Breaks New Ground with BHV-8100 There’s a fresh buzz in the biopharma world as Biohaven Ltd. kicks off first-in-human dosing for their novel drug, BHV-8100. This is no small feat, and it could potentially shake up the landscape of treatments for systemic and central nervous system disorders. You know there’s weight behind a drug when it’s aiming for those...

Continue Reading
Nasdaq Sets Date for 2026 Investor Day Event

Updated Category News Views 372

Exciting Announcement from Nasdaq Nasdaq recently shared significant news regarding its upcoming 2026 Investor Day. Scheduled for the morning of February 25, 2026, this highly anticipated event will take place at the Nasdaq Global Headquarters in Times Square. This annual gathering is essential for investors as it provides insights into the company's strategic direction...

Continue Reading
Acreage Holdings Restructures Debt Agreement for Growth

Updated Category News Views 89

Acreage Holdings Restructures Debt Agreement with Canopy USA Acreage Holdings (OTC: ACRGF), Inc. is a diversified cannabis company, recently announced a strategic amendment to its debt agreement with Canopy USA, LLC, which impacts the payment terms of its outstanding obligations. This pivotal financial maneuver came into effect recently and is a reflection of the...

Continue Reading
Chlorella Market Projected Growth and Nutritional Benefits

Updated Category News Views 233

Understanding the Growth of the Chlorella Market Chlorella occupies an important place in the sphere of superfoods. This vibrant freshwater alga, famous for its rich nutritional profile, plays a vital role in the health and wellness trend that is sweeping across the globe. It is known for its presence in pills, powders, capsules, and liquid extracts, marking its...

Continue Reading